Biomarin Fair Value
BM
The fair market value of BMRN stock is 210.06 USD. Relative to the market price of 66.4758 USD Biomarin is undervalued by 216.4%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Biomarin Valuation
Current BMRN share ticker price is 66.4758 USD.
The fair value level of 210.06 USD can be considered as an effective entry point for long-term investors to start investing in BMRN stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 216% lower its fair value
Current price is 53% higher its minimum value
Current price is 626% lower its maximum value
Market price:
BMRN stock is undervalued
It means the current price may concern as a Moderate Risk Entry Point
Biomarin Pharmaceutical Inc Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
284.07
2
Median P/E over 5 years
123.59
3
Minimum P/E over 5 years
18.21
4
Earning per share (last 12 months)
1.7 USD
Maximum value
1
x
4
=
482.84 USD
Fair value
2
x
4
=
210.06 USD
Minimum value
3
x
4
=
30.96 USD
Biomarin Pharmaceutical Inc price metrics
-3.35
Annual return (geometric mean)
39.65
Risk (standard deviation) of returns
β
0.28
Beta (volatility compared to market)